SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 490 filers reported holding SEATTLE GENETICS INC in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $702,216 | +32.7% | 3,310 | +20.4% | 0.04% | +37.9% |
Q2 2023 | $529,265 | -4.9% | 2,750 | 0.0% | 0.03% | -12.1% |
Q1 2023 | $556,792 | +57.6% | 2,750 | 0.0% | 0.03% | +50.0% |
Q4 2022 | $353,402 | -6.0% | 2,750 | 0.0% | 0.02% | -15.4% |
Q3 2022 | $376,000 | -22.8% | 2,750 | 0.0% | 0.03% | -18.8% |
Q2 2022 | $487,000 | +23.0% | 2,750 | 0.0% | 0.03% | +45.5% |
Q1 2022 | $396,000 | -6.8% | 2,750 | 0.0% | 0.02% | +4.8% |
Q4 2021 | $425,000 | -9.0% | 2,750 | 0.0% | 0.02% | -19.2% |
Q3 2021 | $467,000 | +64.4% | 2,750 | +52.8% | 0.03% | +62.5% |
Q2 2021 | $284,000 | +13.6% | 1,800 | 0.0% | 0.02% | +6.7% |
Q1 2021 | $250,000 | -20.6% | 1,800 | 0.0% | 0.02% | -25.0% |
Q4 2020 | $315,000 | +21.6% | 1,800 | +35.8% | 0.02% | +5.3% |
Q3 2020 | $259,000 | +13.1% | 1,325 | -1.5% | 0.02% | +5.6% |
Q2 2020 | $229,000 | – | 1,345 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 45,725,556 | $2,365,840,000 | 20.68% |
Lagoda Investment Management, L.P. | 398,529 | $20,620,000 | 7.88% |
Matrix Capital Management Company, LP | 2,118,000 | $109,585,000 | 3.72% |
Ghost Tree Capital, LLC | 300,000 | $15,522,000 | 3.23% |
Sio Capital Management, LLC | 100,000 | $5,174,000 | 2.46% |
GREAT POINT PARTNERS LLC | 249,500 | $12,909,000 | 2.31% |
Redmile Group, LLC | 665,139 | $34,414,000 | 2.10% |
Eventide Asset Management | 525,000 | $27,164,000 | 1.69% |
Opus Point Partners Management, LLC | 35,093 | $1,816,000 | 1.66% |
Boxer Capital, LLC | 125,000 | $6,468,000 | 1.54% |